Healio: No difference in sustained health status improvements in TAVR vs. surgical AVR
Patients who had transcatheter aortic valve replacement (TAVR) had similar health status after five years with those who had surgical AVR, although there was a short-term health status benefit in the TAVR group, according to a new study.
Dr. Suzanne Arnold, cardiologist at Saint Luke’s Mid America Heart Institute, and colleagues studied high-risk patients with severe aortic stenosis who had either TAVR or surgical AVR.
"Surviving patients treated with either TAVR or surgical AVR had substantial improvements in disease-specific and generic health status," Dr. Arnold said. "These improvements were maximal at approximately 6 to 12 months and maintained through 2 years with gradual decline in physical health status thereafter."
Read the full Healio article: No difference in sustained health status improvements in TAVR vs. surgical AVR